Serina Therapeutics (SER) Revenue (2018 - 2025)
Serina Therapeutics' (SER) quarterly Revenue came in at $130000.0 in Q2 2025, up 154.9% year-over-year from $51000.0 in Q2 2024, and up 1028.57% quarter-over-quarter from -$14000.0 in Q4 2024.
Powered by 
Analysis
Serina Therapeutics (SER) Revenue (2018 - 2025) Analysis & Trends
Serina Therapeutics has disclosed Revenue across 8 years of filings, most recently posting $130000.0 for Q2 2025.
- In Q2 2025, Revenue rose 154.9% year-over-year to $130000.0; the TTM figure through Jun 2026 stood at $130000.0 (changed 0.0% YoY), while the FY2025 annual figure was $130000.0, up 132.14% from the prior year.
- Revenue came in at $130000.0 for Q2 2025 at Serina Therapeutics, up from -$14000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $3.1 million in Q4 2023 to a low of -$14000.0 in Q4 2024.
- Average Revenue over 5 years is $218125.0, with a median of $19000.0 recorded in 2021.
- Year-over-year, Revenue surged 38487.5% in 2023 and tumbled 100.45% in 2024.
- Over 5 years, Revenue stood at $24000.0 in 2021, then plunged by 66.67% to $8000.0 in 2022, then surged by 38487.5% to $3.1 million in 2023, then tumbled by 100.45% to -$14000.0 in 2024, then surged by 1028.57% to $130000.0 in 2025.
- Per Business Quant data, the three most recent Revenue figures were $130000.0 in Q2 2025, -$14000.0 in Q4 2024, and $14000.0 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.67 Bn | 192.69 Bn | 7.24 Bn | 10.05 Bn |
| 2 | Gilead Sciences | 180.06 Bn | 176.88 Bn | 6.22 Bn | 7.80 Bn |
| 3 | Vertex Pharmaceuticals | 131.44 Bn | 123.59 Bn | 2.84 Bn | 3.33 Bn |
| 4 | Regeneron Pharmaceuticals | 81.94 Bn | 73.95 Bn | 3.93 Bn | 4.29 Bn |
| 5 | Argenx Se | 60.28 Bn | 55.10 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 53.87 Bn | 48.73 Bn | 52.00 Mn | 145.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.15 Bn | 29.85 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Biogen | 31.88 Bn | 30.60 Bn | 1.96 Bn | 2.74 Bn |
| 9 | Roivant Sciences | 29.16 Bn | 29.16 Bn | 1.16 Mn | 1.44 Mn |
| 10 | Serina Therapeutics | 39.82 Mn | 16.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 130,000.00 |
| Dec 31, 2024 | -14,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 51,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 3.09 Mn |
| Sep 30, 2023 | 29,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Sep 30, 2021 | 24,000.00 |
| Jun 30, 2021 | 37,000.00 |
| Mar 31, 2021 | 56,000.00 |
| Dec 31, 2020 | 158,000.00 |
| Sep 30, 2020 | 69,000.00 |
| Jun 30, 2020 | 45,000.00 |
| Mar 31, 2020 | 89,000.00 |